Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | Patent Number 11845808

US 11845808 B2
Application Number17149509
Publication NumberUS 20210261622 A1
Pendency2 years, 11 months, 9 days
Filled DateJan 14, 2021
Priority DateJan 15, 2020
Publication DateAug 26, 2021
Expiration DateJan 14, 2040
Inventor/ApplicantsBrian Troy Frederick
Elisabetta Bianchi
Raymond Patch
Chengzao Sun
Raffaele Ingenito
Gregory Thomas Bourne
Ashok Bhandari
Roberto Costante
Danila Branca
Sandeep Somani
ExaminesCOFFA, SERGIO
Art Unit1658
Technology Center1600
Assignments
Janssen Biotech Inc.
Current
Janssen Biotech Inc.Johnson & Johnson
Original
Protagonist Therapeutics Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.